Loading market data...
markets

Should You Add Illumina Stock to Your Portfolio Now?

Yahoo Finance
Read Full Article at Yahoo Finance
Share:PostShare
Ad Slot — In-Article (728x90)

ILMN's sequencing growth, oncology momentum and multiomics expansion support its outlook, though cost volatility may pressure margins.

This is a summary. For the full story, read the original article at Yahoo Finance.

Original source: Yahoo Finance

Ad Slot — Below Article (300x250)